WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr | ₹1,012 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹60 Cr |
Mar2023 | ₹1,072 Cr |
Mar2022 | ₹934 Cr |
Mar2021 | ₹889 Cr |
Mar2020 | ₹1,012 Cr |
How is Contingent Liabilities of WANBURY Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹60 Cr | -94.40 | |
Mar2023 | ₹1,072 Cr | 14.78 | |
Mar2022 | ₹934 Cr | 5.01 | |
Mar2021 | ₹889 Cr | -12.14 | |
Mar2020 | ₹1,012 Cr | - |
Compare Contingent Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹952.6 Cr | 6.1% | 16.1% | 43.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,498.0 Cr | 1.9% | -2.1% | -6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,334.0 Cr | 2.7% | -5.6% | 25.2% | Stock Analytics | |
CIPLA | ₹127,613.0 Cr | 3.4% | 7.7% | 0.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,235.0 Cr | 0.6% | 4.4% | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,437.0 Cr | 3.2% | 1.6% | -8.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 6.1% |
16.1% |
43.7% |
SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses